GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 179   

Articles published

GSK 54.99 -0.31 (-0.56%)
price chart
ADR Shares End Mixed; Novartis, Glaxo, Philips Shares Active
... (PHG, PHIA.AE). Drug giants Novartis and GlaxoSmithKline unveiled a series of transactions worth more than $20 billion that fundamentally transform both companies, focusing Novartis's scope without significantly hitting its revenue and turning ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) Divests Cancer Unit, Enters Joint ...  US Trade Media
Novartis Trying to Simplify Business; Announces Deals With Glaxo And Eli Lilly  Bidness Etc
Related articles »  
New GlaxoSmithKline Diabetes Drug Needs Innovative Marketing Strategy
The drug is albiglutide, marketed by GSK in the U.S. as Tanzeum, and approved by FDA on 15 April as a way for adults with type 2 diabetes to control their blood sugar levels, when used with diet and exercise.
GlaxoSmithKline plc (ADR) (NYSE:GSK): A Drug To Tackle Bribery Scandals
Tomahawk, WI 04/15/2014 (Basicsmedia) - It's not like GlaxoSmithKline plc (ADR) (NYSE:GSK) is the only drug maker that has the tendency to get ensnared in corruption and bribery scandals.
GSK investigated in Poland for alleged bribery  Seeking Alpha
Related articles »  
The Appeal Of Biotechs In Orphan Diseases [Gilead Sciences, Inc., BioMarin ...
biotechnology To cast a spotlight on disruptive biotechnology stocks, Raghuram �Ram� Selvaraju of Aegis Capital Corp. taps his experience as a molecular biologist, preclinical investigator and sellside analyst.
GlaxoSmithKline plc (ADR) (NYSE:GSK) To Investigate Bribery In Iraq
Tomahawk, WI 04/08/2014 (Basicsmedia) - British drugs maker GlaxoSmithKline plc (ADR) (NYSE:GSK) is all set to investigate bribery charges in Iraq, the company said on Sunday.
GSK probes possible corruption in Iraq  Seeking Alpha
Related articles »  
Brand Face-Off: GlaxoSmithKline plc (ADR) vs. Merck & Co., Inc.
Pharmaceutical giants GlaxoSmithKline plc (ADR) (NYSE:GSK) and Merck & Co., Inc. (NYSE:MRK) have charted different paths during the last year.
Related articles »  
Amgen, Inc. Pays GlaxoSmithKline plc (ADR) to Go Away
Amgen (NASDAQ: AMGN ) has decided to pay off its Big Pharma partner GlaxoSmithKline (NYSE: GSK ) in order to part ways on its international marketing agreement with the company over its drug Denosumab, also known as Prolia, in the treatment of ...
Related articles »  
GlaxoSmithKline plc (ADR) (GSK): Significant Upside For The Stock
technical chart look Rick Pendergraft: Pharmaceutical giant GlaxoSmithKline plc (ADR) (NYSE:GSK) caught my attention last night as the stock has formed an island bottom.
Stocks To Watch: iCAD Inc (NASDAQ:ICAD), GlaxoSmithKline plc (ADR)(NYSE ...
British pharmaceutical giant GlaxoSmithKline plc (ADR) (NYSE:GSK) announced yesterday, April 13th, that the company is under investigation for bribery in Poland.
Related articles »  
GlaxoSmithKline plc (ADR) (NYSE:GSK): Markets Take Note of the Pharma ...
Dallas, Texas 03/27/2014 (ustradevoice) - GlaxoSmithKline plc (ADR) (NYSE:GSK) has become a hot pick in the current day market.
Related articles »